Norton Cancer Center

Louisville, Kentucky 40241

2 studies enrolling now · 8 studies all time

What they study most

Advanced Solid Tumor, Advanced or Metastatic Cutaneous Squamous Cell Carcinoma, Advanced or Metastatic Head and Neck Squamous Cell Carcinoma, Advanced or Metastatic Melanoma, Advanced or Metastatic Merkel Cell Carcinoma, Advanced or Metastatic Solid Tumors, Bladder Cancer, Cutaneous Melanoma, Esophageal Adenocarcinoma, Gastric Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Melanoma

Studies at this site

• Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors — Recruiting now
• Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors — Recruiting now
• Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6 — Stopped early
• Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer — Stopped early
• SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE) — Status unconfirmed
• Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma — Stopped early
• A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen — Completed
• Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, or Other Advanced Solid Tumors — Stopped early